Search Within

Alfredo Amador Molina

Formats
  1. Editorial (3)
  2. Journal Article (2)
  3. Meeting Abstract (2)
  4. Review (1)
Groups
  1. Sloan Kettering Institute Postdocs (8)
  2. Surgery (8)
  3. Center for Hematologic Malignancies (1)
  4. Department of Medicine (1)
  5. GDMT, Medicine (1)
  6. GME, Surgery (1)

More Groups

People
  1. Prasad Adusumilli (8)
  2. Zhaohua Hou (5)
  3. Navin Chintala (4)
  4. Rebecca Bellis (4)
  5. Jasmeen Saini (3)
  6. Srijita Banerjee (3)

More People

Years
  1. 2024 (1)
  2. 2023 (3)
  3. 2022 (3)
  4. 2021 (1)
Publications
  1. Annals of Oncology (1)
  2. Cancer Cell (1)
  3. Cancer Immunology Research (1)
  4. Expert Opinion on Investigational Drugs (1)
  5. Journal of Immunology (1)
  6. Journal of Thoracic and Cardiovascular Surgery (1)

More Publications

Publishers
  1. American Association for Cancer Research (1)
  2. Cell Press (1)
  3. Mosby Elsevier (1)
  4. Nature Research (1)
  5. Oxford University Press (1)
  6. Taylor & Francis Group (1)

More Publishers

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • DLL3-targeted CAR T-cell therapy in pre-clinical models for small cell lung cancer: Safety, efficacy, and challenges
    Editorial

    Bellis, R. Y.; Adusumilli, P. S.; Amador-Molina, A.
    Translational Lung Cancer Research (2024)

    Fulltext@MSK | Save
  • CAR T-cell intrinsic PD1 dominant negative receptor (PD1DNR) functions by both cell-intrinsic and extrinsic mechanisms
    Meeting Abstract

    Amador, A.; Hou, Z.; Chintala, N.; Adusumilli, P. S.
    Journal of Immunology (2023)

    Fulltext@MSK | Save
  • Tumor-targeted nonablative radiation promotes solid tumor CAR T-cell therapy efficacy
    Journal Article

    Quach, H. T.; Skovgard, M. S.; Villena-Vargas, J.; Bellis, R. Y.; Chintala, N. K.; Amador-Molina, A.; Bai, Y.; Banerjee, S.; Saini, J.; Xiong, Y.; more...
    Cancer Immunology Research (2023)

    Fulltext@MSK | Save
  • c-Kit signaling potentiates CAR T cell efficacy in solid tumors by CD28- and IL-2-independent co-stimulation
    Journal Article

    Xiong, Y.; Taleb, M.; Misawa, K.; Hou, Z.; Banerjee, S.; Amador-Molina, A.; Jones, D. R.; Chintala, N. K.; Adusumilli, P. S.
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • Next-generation immunotherapy for solid tumors: Combination immunotherapy with crosstalk blockade of TGFβ and PD-1/PD-L1
    Review

    Quach, H. T.; Hou, Z.; Bellis, R. Y.; Saini, J. K.; Amador-Molina, A.; Adusumilli, P. S.; Xiong, Y.
    Expert Opinion on Investigational Drugs (2022)

    Fulltext@MSK | Save
  • Commentary: Regional oncolytics for pleural malignancies
    Editorial

    Amador, A.; Byun, A. J.; Adusumilli, P. S.
    Journal of Thoracic and Cardiovascular Surgery (2022)

    Fulltext@MSK | Save
  • Regional CAR T cell therapy: An ignition key for systemic immunity in solid tumors
    Editorial

    Cherkassky, L.; Hou, Z.; Amador-Molina, A.; Adusumilli, P. S.
    Cancer Cell (2022)

    Fulltext@MSK | Save
  • Promoting functional persistence in solid tumor CAR T-cell therapy: Mesothelin-targeted CAR (M28z1XXPD1DNR) with T-cell intrinsic PD1 dominant negative receptor
    Meeting Abstract

    Adusumilli, P. S.; Amador, A. M.; Chintala, N.; Hou, Z.; Offin, M.; Pineda, J.; Senechal, B.; Quach, H. T.; Bellis, R.; Banerjee, S.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save